2014
DOI: 10.1007/s11239-014-1078-1
|View full text |Cite
|
Sign up to set email alerts
|

Platelet aggregation and coagulation factors in orthopedic surgery

Abstract: Hemostasis is a major concern during the perioperative period. Changes in platelet aggregation and coagulation factors may contribute to the delicate balance between thrombosis and bleeding. We sought to better understand perioperative hemostasis by investigating the changes in platelet aggregation and coagulation factors during the perioperative period. We performed a prospective cohort analysis of 70 subjects undergoing non-emergent orthopedic surgery of the knee (n = 28), hip (n = 35), or spine (n = 7) betw… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
15
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 15 publications
(17 citation statements)
references
References 33 publications
2
15
0
Order By: Relevance
“…Another advantage of these apparatuses, with the tests being performed on whole blood, is the capability to simultaneously study the interactions between platelets, cells and coagulation factors. Only a few studies have evaluated the use of thromboelastometry/graphy in patients undergoing MEOS [9][10][11][12][13][14][15]. However, none of them evaluated the determinants of significant bleeding.…”
Section: Introductionmentioning
confidence: 99%
“…Another advantage of these apparatuses, with the tests being performed on whole blood, is the capability to simultaneously study the interactions between platelets, cells and coagulation factors. Only a few studies have evaluated the use of thromboelastometry/graphy in patients undergoing MEOS [9][10][11][12][13][14][15]. However, none of them evaluated the determinants of significant bleeding.…”
Section: Introductionmentioning
confidence: 99%
“…Endothelial dysfunction, microvascular coronary disease, aberrant inflammatory pathways, and heightened platelet activity may be contributing mechanisms. 22,23 …”
Section: Discussionmentioning
confidence: 99%
“…Increases in platelet aggregation and coagulation factor activities can be identified through 7 days after surgery. [85][86][87] Antiplatelet VTE prophylaxis with low-dose aspirin in human orthopedic patients was found to reduce the incidence of PE by 43% without an increased risk of major bleeding. 50 However, low-dose aspirin is associated with a 50% increase in upper gastrointestinal bleeding, a risk that is dose dependent and reduced with the concurrent administration of proton pump inhibitors.…”
Section: Surgery-specific Modificationsmentioning
confidence: 99%